An antagonist of mGluR5a
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

SIB 1757

Item No. 35442

Product Insert (PDF)Safety Data Sheet (SDS) (PDF)
Technical Information
Formal Name
6-methyl-2-(2-phenyldiazenyl)-3-pyridinol
CAS Number
31993-01-8
Molecular Formula
C12H11N3O
Formula Weight
213.2
Purity
≥95%
Formulation
A solid
Solubility(Learn about Variance in Solubility)
DMF: 14 mg/mlDMSO: 14 mg/mlEthanol: 5 mg/mlPBS (pH 7.2): 0.11 mg/ml
λmax
238, 300, 383 nm
SMILES
OC1=C(/N=N/C2=CC=CC=C2)N=C(C)C=C1
InChi Code
InChI=1S/C12H11N3O/c1-9-7-8-11(16)12(13-9)15-14-10-5-3-2-4-6-10/h2-8,16H,1H3/b15-14+
InChi Key
LOCPVWIREQIGNQ-CCEZHUSRSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Download most recent Certificate of Analysis for this product

    5 mg

    $48

    Add

    10 mg

    $85

    Add

    25 mg

    $165

    Add

    50 mg

    $306

    Add
    Product Description

    SIB 1757 is an antagonist of metabotropic glutamate receptor 5a (mGluR5a).1 It selectively inhibits glutamate-induced calcium release and quisqualate-induced phosphoinositol accumulation in fibroblasts expressing human mGluR5a (IC50s = 0.37 and 3.1 µM, respectively) over mGluR1b-expressing fibroblasts (IC50s = >100 µM for both). SIB 1757 is also selective for mGluR5a over mGluR2, mGluR3, mGluR4a, mGluR6, mGluR7b, mGluR8 (IC50s = >100 µM for all), as well as AMPA, kainate, and NMDA receptors (IC50s = >30 µM for all). It inhibits phosphoinositol accumulation induced by the group I mGluR agonist (S)-3,5-DHPG (Item No. 14411) in isolated neonatal rat hippocampus and striatum (IC50s = 5.2 and 10.1 µM, respectively). Intrathecal administration of SIB 1757 (0.01 µg/animal) increases the paw withdrawal threshold in a rat model of neuropathic pain induced by spinal nerve ligation.2

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Varney, M.A., Cosford, N.D., Jachec, C., et al. SIB-1757 and SIB-1893: Selective, noncompetitive antagonists of metabotropic glutamate receptor type 5. J. Pharmacol. Exp. Ther. 290(1), 170-181 (1999).

    2. Dogrul, A., Ossipov, M.H., Lai, J., et al. Peripheral and spinal antihyperalgesic activity of SIB-1757, a metabotropic glutamate receptor (mGLUR5) antagonist, in experimental neuropathic pain in rats. Neurosci. Lett. 292(2), 115-118 (2000).